Xyzal (levocetirizine dihydrochloride Oral Tabs)Xyzal (levocetirizine dihydrochloride Oral Solution)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
ADVERSE REACTIONS
Post-Marketing Experience
Addition to listing of adverse reactions...arthralgia
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Marketing